Search results
How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - San...
The Business Journals· 5 days agoA drug traded between companies for 20 years — and approved by regulators in April to treat brain ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 3 hours agoIn that vein, consider Bristol Myers Squibb, a pharmaceutical giant that lost patent exclusivity for cancer drug Revlimid, its former top-selling
South Korea seeks to accelerate drug reimbursement administration process
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe CDDC approval is the first step towards reimbursement for a cancer treatment. Drugs that passed...
FDA authorizes first menthol-flavored e-cigarettes for adult smokers
ABC7 New York· 41 minutes agoThe Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the ...
Appeals court does not block US mandate to cover cancer screenings, HIV drugs
Reuters· 15 hours agoA U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to cover...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 4 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Appeals court does not block US mandate to cover cancer screenings, HIV drugs
Reuters via Yahoo News· 18 hours ago(Reuters) -A U.S. appeals court on Friday refused to block a federal mandate requiring health...
US FDA approves Bristol Myers’ colorectal cancer therapy
WHTC 1450 Holland· 20 hours ago(Reuters) - The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination...
Radioactive drugs strike cancer with precision
Ars Technica· 1 day agoOn a Wednesday morning in late January 1896 at a small light bulb factory in Chicago, a middle-aged woman named Rose Lee found herself at the heart of a...
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 3 days agoAstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did...